Professor Mark Rosenthal is a Senior Staff Specialist in the Department of Medical Oncology at the Peter MacCallum Cancer Centre and Director of the Parkville Cancer Clinical Trials Unit. His major interests include: neuro-oncology, prostate cancer and early phase clinical trials.
Professor Rosenthal trained as a Medical Oncologist in Melbourne and Sydney, Australia. He was awarded a Doctorate of Philosophy for a thesis examining the molecular genetics of colon cancer conducted at the Ludwig Institute for Cancer Research. (1992-1996). He completed post-graduate training at New York University Medical Centre, New York, USA (1996-98) was a Senior Staff Specialist in the Department of Medical Oncology, Royal Melbourne Hospital (1998-2016) and Professor Director of the Department from 2006-2016. He was Chairman and Chief Medical Officer of Cancer Trials Australia (2006-2016) and is Chairman of the Cooperative Trials Group for Neuro-Oncology (COGNO).